Locations:
Search IconSearch
April 24, 2020/COVID-19

Postponing Cochlear Implant Surgery Is Difficult but Necessary During the COVID-19 Crisis

Cleveland Clinic experts provide commentary

19-ENT-4248-CochlearImplant-hero-650×450

During this unprecedented time, cochlear implant (CI) procedures, considered an elective surgery, are being put on hold — indefinitely in some states. CI and other otologic surgeries often provide significant clinical benefit to patients for whom these procedures are indicated. In an effort to preserve personal protective equipment and other critical resources, the hearing health community is weighing in on the difficult, albeit necessary, decision to postpone these procedures.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Erika Woodson, MD, Section Head, Otology-Neurotology and Medical Director of the Hearing Implant Program, and Sarah Sydlowski, AuD, PhD, Audiology Director, Hearing Implant Program, both of Cleveland Clinic’s Head & Neck Institute, discuss the necessity of suspending CI surgery during the COVID-19 crisis.

Their commentary was recently published in The Hearing Journal.

Advertisement

Related Articles

Stellate Ganglion Block
May 17, 2023/COVID-19
Nerve Block Shows Promise for Long COVID-Related Olfactory or Gustatory Dysfunction

Patients report improved sense of smell and taste

Covid image
April 26, 2023/COVID-19
What Long COVID Means for Rheumatologists (Video)

Clinicians who are accustomed to uncertainty can do well by patients

Covid related skin effects
April 4, 2023/COVID-19
Cutaneous Manifestations of COVID-19 in Special Populations

Unique skin changes can occur after infection or vaccine

Glucometer
February 10, 2023/COVID-19
Effects of COVID-19 on Blood Sugar and Type 2 Diabetes

Cleveland Clinic analysis suggests that obtaining care for the virus might reveal a previously undiagnosed condition

covid-19
January 13, 2023/COVID-19
Optimal Management of High Risk Immunocompromised Patients in the COVID-19 Era

As the pandemic evolves, rheumatologists must continue to be mindful of most vulnerable patients

covid-19 virus
January 12, 2023/COVID-19
Real World Experience with Tixagevimab/Cilgavimab in B-Cell-Depleted Patients

Early results suggest positive outcomes from COVID-19 PrEP treatment

Eosinophilic Fasciitis
November 29, 2022/COVID-19
New Onset Eosinophilic Fasciitis after COVID-19 Infection

Could the virus have caused the condition or triggered previously undiagnosed disease?

Ad